Third dose of anti-SARS-CoV-2 inactivated vaccine for patients with RA: Focusing on immunogenicity and effects of RA drugs

OBJECTIVES: To evaluate the immunogenicity of the third dose of inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (RA) patients and explore the effect of RA drugs on vaccine immunogenicity. METHODS: We recruited RA patients (n = 222) and healthy controls (HC, n = 177) who had been injected with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ting, Wang, Bo, Shen, Jiayan, Wei, Yuanyuan, Zhu, Youyang, Tian, Xiaofang, Wen, Guangfen, Xu, Bonan, Fu, Chenyang, Xie, Zhaohu, Xi, Yujiang, Li, Zhenmin, Peng, Jiangyun, Wu, Yang, Tang, Xiaohu, Wan, Chunping, Pan, Lei, Zhu, Wenxin, Li, Zhaofu, Qin, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470915/
https://www.ncbi.nlm.nih.gov/pubmed/36117981
http://dx.doi.org/10.3389/fmed.2022.978272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470915/
https://www.ncbi.nlm.nih.gov/pubmed/36117981
http://dx.doi.org/10.3389/fmed.2022.978272

Ejemplares similares